Literature DB >> 16876748

Verapamil decreases ventricular tachyarrhythmias in a patient with Timothy syndrome (LQT8).

Avrum Jacobs1, Bradley P Knight, Karen T McDonald, Martin C Burke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16876748     DOI： 10.1016/j.hrthm.2006.04.024

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN： 1547-5271            Impact factor:   6.343


× No keyword cloud information.
  23 in total

Review 1.  Inherited calcium channelopathies in the pathophysiology of arrhythmias.

Authors:  Luigi Venetucci; Marco Denegri; Carlo Napolitano; Silvia G Priori
Journal:  Nat Rev Cardiol       Date:  2012-06-26       Impact factor: 32.419

2.  Dysfunctional Cav1.2 channel in Timothy syndrome, from cell to bedside.

Authors:  Dan Han; Xiaolin Xue; Yang Yan; Guoliang Li
Journal:  Exp Biol Med (Maywood)       Date:  2019-07-19

Review 3.  MicroRNA regulation of cardiac conduction and arrhythmias.

Authors:  Gene H Kim
Journal:  Transl Res       Date:  2012-12-27       Impact factor: 7.012

4.  The Timothy syndrome mutation of cardiac CaV1.2 (L-type) channels: multiple altered gating mechanisms and pharmacological restoration of inactivation.

Authors:  Viktor Yarotskyy; Guofeng Gao; Blaise Z Peterson; Keith S Elmslie
Journal:  J Physiol       Date:  2008-12-15       Impact factor: 5.182

5.  Long QT syndrome: A therapeutic challenge.

Authors:  Maully Shah; Christopher Carter
Journal:  Ann Pediatr Cardiol       Date:  2008-01

6.  Molecular endpoints of Ca2+/calmodulin- and voltage-dependent inactivation of Ca(v)1.3 channels.

Authors:  Michael R Tadross; Manu Ben Johny; David T Yue
Journal:  J Gen Physiol       Date:  2010-02-08       Impact factor: 4.086

7.  Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine.

Authors:  Serge Sicouri; Katherine W Timothy; Andrew C Zygmunt; Aaron Glass; Robert J Goodrow; Luiz Belardinelli; Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2007-01-07       Impact factor: 6.343

Review 8.  Pharmacological approach to the treatment of long and short QT syndromes.

Authors:  Chinmay Patel; Charles Antzelevitch
Journal:  Pharmacol Ther       Date:  2008-04       Impact factor: 12.310

9.  A case report: Is mexiletine usage effective in the shortening of QTC interval and improving the T-wave alternans in Timothy syndrome?

Authors:  Gulhan Tunca Sahin; Yakup Ergul
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-11-30       Impact factor: 1.468

Review 10.  CaV1.2 channelopathies: from arrhythmias to autism, bipolar disorder, and immunodeficiency.

Authors:  Ping Liao; Tuck Wah Soong
Journal:  Pflugers Arch       Date:  2009-11-15       Impact factor: 3.657
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.